Literature DB >> 18539615

Infusion of trastuzumab maintenance doses over 30 minutes.

A Ring1, R Simcock2, S Mitra3, D Bloomfield2, J King2, S Simpson3, G Sadler4, A Webb2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18539615     DOI： 10.1093/annonc/mdn390

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Incidence, risk factors, and management of infusion-related reactions in breast cancer patients receiving trastuzumab.

Authors:  Lisa M Thompson; Karen Eckmann; Bonnie L Boster; Kenneth R Hess; Laura B Michaud; Francisco J Esteva; Gabriel N Hortobágyi; Chad M Barnett
Journal:  Oncologist       Date:  2014-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.